Latest news with #KLEUniversity
Fashion Value Chain
2 days ago
- Health
- Fashion Value Chain
Xavier University School of Medicine, Aruba and KLE University Launch International Medical Program for Indian Students Aspiring to Practice in the US and Canada
With a growing number of Indian students aspiring to pursue medical education and careers in the United States, Canada, and beyond, Xavier University School of Medicine, Aruba (XUSOM), in collaboration with KLE University, India, has launched a unique international medical pathway to support this ambition. This innovative program allows students to begin their medical journey in India at KLE University's Belgaum campus, continue with their preclinical sciences education at XUSOM, and then complete clinical rotations at Xavier's affiliated and accredited teaching hospitals across the United States. Students will spend the first year completing pre-health coursework at KLE's campus in Belgaum, India. They will then advance to Xavier's state-of-the-art campus in Aruba for basic science training before transitioning to hands-on clinical experiences in the United States. By starting their studies at KLE and transitioning smoothly to Xavier University in Aruba, students benefit from a unique and accessible pathway to a global medical career. Designed specifically for high school graduates and aspiring doctors aiming to practice in North America, this program offers a seamless, structured path to meet the rigorous standards required for medical licensure in the US and Canada. 'This association presents a clear and compelling opportunity for students in India who dream of becoming doctors in North America,' said Mamta Purbey, Director of Admissions & Marketingat XUSOM. 'We take pride in offering Indian students not only a robust academic curriculum but also personalized guidance and support throughout their medical education journey. Our dedicated team ensures students navigate each stage smoothly – from admission through clinical rotations – equipping them to successfully achieve their goal of practicing medicine in the US, and Canada.' 'This collaboration brings together a globally aligned medical curriculum taught by experienced and highly qualified faculty, ensuring students gain the knowledge, skills, and international exposure needed to excel in today's competitive medical field,' said Dr. Arun Kumar Dubey, Chief Academic Officerof XUSOM. 'Our mission is to eliminate uncertainty for aspiring medical professionals by offering a clear, structured, and academically rigorous pathway – from India to Aruba to the United States – ultimately preparing them to succeed in medical practice across North America.' 'This partnership marks a significant step toward removing barriers and providing clear guidance for Indian students determined to pursue a medical career abroad.' 'This partnership with KLE University represents a shared commitment to creating accessible, world-class medical education pathways for talented students in India,' said Ravi Bhooplapur, President of XUSOM. 'By combining KLE's strong foundation in pre-health sciences with Xavier's globally recognized medical curriculum and clinical training opportunities in the United States, we are empowering the next generation of doctors to achieve their dream of practicing medicine in North America.' For more details on Xavier University School of Medicine visitXUSOM Website.
Time of India
16-05-2025
- Health
- Time of India
'Irrational' fixed dose combos harmful, may face ban: Expert panel
New Delhi: Personal care products containing aloe vera, jojoba oil and orange oil may be harmful and are likely to be banned soon after the expert committee looking into these fixed dose combinations (FDCs) found they may pose a risk to human beings. Considering that they are "irrational," the experts have recommended their prohibition. There are about 16 odd FDCs including Aloe Vera+Jojoba oil+Vitamin E, Aloe Vera+Orange Oil, Aloe Vera+Vitamin E+Herbal, Aloe Vera+Jojoba Oil+wheat germ oil+Tea Tree oil, among others, which are likely to be part of a list of products to be banned. The other FDCs which fall under the same category are Paracetamol + Lidocaine, acetyl salicylic acid+ethoheptazine used as pain relievers. They have been under the government scanner from 2021. A FDC contains two or more active ingredients in a fixed dose ratio, but in India several FDCs are found to be irrational or are not scientifically validated for safety or efficacy through rigorous tests for patients. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like New Container Houses Vietnam (Prices May Surprise You) Container House | Search Ads Search Now Undo Earlier in March 2023, companies producing such FDCs were asked to give a presentation, representing their case justifying the need for these products. The companies were asked to submit a summary with the "highest level of evidence," supporting the claim of postulated advantage/rationale, along with the published data regarding safety and efficacy of FDC. They were asked to share whether these FDCs are marketed in the EU, UK, Canada, Australia, Japan and the US. The companies were also told to mention country wise product names, ingredients, dosage forms, it's strength, amount of usual ingredients per dosage form and the countries where the drug is marketed, approved, withdrawn, among other details. Live Events "The companies were heard out and it was found that "there is no therapeutic justification" for these FDCs, and they may involve "risk" to human beings," said a senior government official. "Hence, in the larger public interest, it is necessary to prohibit the manufacture, sale or distribution of this FDC", another person said. They were earlier considered as "irrational" by a panel led by Chandrakant Kokate, vice-chancellor of KLE University in Karnataka. However, a sub-committee formed under the chairmanship of Nilima Kshirsagar, former dean of G.S. Medical College and KEM Hospital in Mumbai, was asked to examine and review the safety, efficacy and therapeutic justification of these drugs. The sub-committee recommended "prohibition" of these FDCs, saying they could pose a risk to human beings. Last month the report was submitted before India's top technical body on drugs which agreed with the recommendations of the subcommittee. "The recommendations have now been sent to the health ministry for further action," added the government official. In India, the overall market for aloe vera combination is worth ₹90. 7 core and growing at 27% annually, PharmaTrac data shows.
